Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cartesian Therapeutics

15.80
-0.8100-4.88%
Post-market: 15.800.00000.00%17:24 EDT
Volume:198.17K
Turnover:3.21M
Market Cap:406.46M
PE:-0.68
High:16.75
Open:16.58
Low:15.80
Close:16.61
Loading ...

Cartesian Therapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
03 Dec 2024

Cartesian Therapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
25 Nov 2024

Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics

Simply Wall St.
·
21 Nov 2024

Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024

GuruFocus
·
14 Nov 2024

Cartesian Therapeutics Receives Buy Rating After Promising Phase 2b Trial Results and Strategic Advancements

TIPRANKS
·
11 Nov 2024

Cartesian Therapeutics Inc expected to post a loss of 80 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Allogene Therapeutics (ALLO) and Moderna (MRNA)

TIPRANKS
·
08 Nov 2024

Cartesian Therapeutics (RNAC) Receives a Hold from Oppenheimer

TIPRANKS
·
08 Nov 2024

Cartesian Therapeutics price target lowered to $41 from $45 at H.C. Wainwright

TIPRANKS
·
08 Nov 2024

Cartesian Therapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
08 Nov 2024

BRIEF-Cartesian Therapeutics Reports Q3 2024 Financial Results And Provides Business Update

Reuters
·
07 Nov 2024

Cartesian Therapeutics Inc: Qtrly Basic Net Loss per Share $1.13

THOMSON REUTERS
·
07 Nov 2024

Insiders of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) must be disappointed as stock fell 10% after recent purchases

Simply Wall St.
·
26 Oct 2024

Bullish Cartesian Therapeutics Insiders Loaded Up On US$5.18m Of Stock

Simply Wall St.
·
18 Oct 2024

Cartesian Therapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
16 Oct 2024

Cartesian Therapeutics Announces Presentation of Results From Phase 2B Trial of Descartes-08 in Patients With Myasthenia Gravis at the 2024 Mgfa Scientific Session of the Aanem Annual Meeting

THOMSON REUTERS
·
15 Oct 2024